In a clinical trial conducted by Assuta Medical Center (NCT02964351), adenocarcinoma PCa patients with high PSA values will be enrolled, and their mRNA expression profiles will be examined using Nano-string technology. The gene discussed is KLK3; the disease is posterior cortical atrophy.